APO RESEARCH · REPORT
Marine Pharmaceuticals
The drug obtained from marine organisms which are being conventionally used like shark and cod-liver oils, sodium alginate, agar-agar, chitin etc.
Product & engineering
Understand the product.
The drug obtained from marine organisms which are being conventionally used like shark and cod-liver oils, sodium alginate, agar-agar, chitin etc.
Marine organisms are potential source for drug discovery. Life has originated from the oceans that cover over 70% of the surface of earth and contain highly ecological, chemical and biological diversity starting from micro-organisms to vertebrates. This diversity has been the source of unique chemical compounds, which hold tremendous pharmaceutical potential.
Selected research
Industry Research
Marine Pharmaceuticals Industry Research Report 2026
Market perspective
The drug obtained from marine organisms which are being conventionally used like shark and cod-liver oils, sodium alginate, agar-agar, chitin etc.
Marine organisms are potential source for drug discovery. Life has originated from the oceans that cover over 70% of the surface of earth and contain highly ecological, chemical and biological diversity starting from micro-organisms to vertebrates. This diversity has been the source of unique chemical compounds, which hold tremendous pharmaceutical potential.
Global Marine Pharmaceuticals key players include Seattle Genetics, Inc., DSM, Eisai Co, Takeda, BASF, Amway, etc. Global top six manufacturers hold a share about 10%.
Read the full market overview
North America is the largest market, with a share about 35%, followed by Europe and China, both have a share over 35 percent.
In terms of product, Health Supplement is the largest segment, with a share about 90%. And in terms of application, the largest application is Pharmacy, followed by Hospital & Clinic.
Report Scope
This report quantifies the global Marine Pharmaceuticals market in terms of revenue (US$ million) and, where applicable, sales volume (M units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/M units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Marine Pharmaceuticals Market by Company
Seattle Genetics
DSM
Eisai Co
Takeda
BASF
Amway
Pfizer
Pelagia (EPAX)
Pharma Mar SA
Croda
GNC
GSK
TerSera Therapeutics
Nordic Naturals
Carlson Labs
Marine Pharmaceuticals Segment by Type
Drugs
Health Supplement
Marine Pharmaceuticals Segment by Application
Hospital & Clinic
Pharmacy
Other
Marine Pharmaceuticals Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Marine Pharmaceuticals market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Marine Pharmaceuticals and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Marine Pharmaceuticals.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Marine Pharmaceuticals manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Marine Pharmaceuticals by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Marine Pharmaceuticals in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Drugs
- Health Supplement
Applications
- Hospital & Clinic
- Pharmacy
- Other
Companies covered
- Seattle Genetics
- DSM
- Eisai Co
- Takeda
- BASF
- Amway
- Pfizer
- Pelagia (EPAX)
- Pharma Mar SA
- Croda
- GNC
- GSK
- TerSera Therapeutics
- Nordic Naturals
- Carlson Labs
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Marine Pharmaceuticals Market Size (2021-2032)
- 2.2.2 Global Marine Pharmaceuticals Sales (2021-2032)
- 2.2.3 Global Marine Pharmaceuticals Market Average Price (2021-2032)
- 2.3 Marine Pharmaceuticals by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Drugs
- 2.3.3 Health Supplement
- 2.4 Marine Pharmaceuticals by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital & Clinic
- 2.4.3 Pharmacy
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Marine Pharmaceuticals Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Marine Pharmaceuticals Sales (M units) of Manufacturers (2021-2026)
- 3.3 Global Marine Pharmaceuticals Revenue of Manufacturers (2021-2026)
- 3.4 Global Marine Pharmaceuticals Average Price by Manufacturers (2021-2026)
- 3.5 Global Marine Pharmaceuticals Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Marine Pharmaceuticals, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Marine Pharmaceuticals, Product Type & Application
- 3.8 Global Manufacturers of Marine Pharmaceuticals, Established Date
- 3.9 Global Marine Pharmaceuticals Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Seattle Genetics
- 4.1.1 Seattle Genetics Company Information
- 4.1.2 Seattle Genetics Business Overview
- 4.1.3 Seattle Genetics Marine Pharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Seattle Genetics Marine Pharmaceuticals Product Portfolio
- 4.1.5 Seattle Genetics Recent Developments
- 4.2 DSM
- 4.2.1 DSM Company Information
- 4.2.2 DSM Business Overview
- 4.2.3 DSM Marine Pharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 DSM Marine Pharmaceuticals Product Portfolio
- 4.2.5 DSM Recent Developments
- 4.3 Eisai Co
- 4.3.1 Eisai Co Company Information
- 4.3.2 Eisai Co Business Overview
- 4.3.3 Eisai Co Marine Pharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Eisai Co Marine Pharmaceuticals Product Portfolio
- 4.3.5 Eisai Co Recent Developments
- 4.4 Takeda
- 4.4.1 Takeda Company Information
- 4.4.2 Takeda Business Overview
- 4.4.3 Takeda Marine Pharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Takeda Marine Pharmaceuticals Product Portfolio
- 4.4.5 Takeda Recent Developments
- 4.5 BASF
- 4.5.1 BASF Company Information
- 4.5.2 BASF Business Overview
- 4.5.3 BASF Marine Pharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 BASF Marine Pharmaceuticals Product Portfolio
- 4.5.5 BASF Recent Developments
- 4.6 Amway
- 4.6.1 Amway Company Information
- 4.6.2 Amway Business Overview
- 4.6.3 Amway Marine Pharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Amway Marine Pharmaceuticals Product Portfolio
- 4.6.5 Amway Recent Developments
- 4.7 Pfizer
- 4.7.1 Pfizer Company Information
- 4.7.2 Pfizer Business Overview
- 4.7.3 Pfizer Marine Pharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Pfizer Marine Pharmaceuticals Product Portfolio
- 4.7.5 Pfizer Recent Developments
- 4.8 Pelagia (EPAX)
- 4.8.1 Pelagia (EPAX) Company Information
- 4.8.2 Pelagia (EPAX) Business Overview
- 4.8.3 Pelagia (EPAX) Marine Pharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Pelagia (EPAX) Marine Pharmaceuticals Product Portfolio
- 4.8.5 Pelagia (EPAX) Recent Developments
- 4.9 Pharma Mar SA
- 4.9.1 Pharma Mar SA Company Information
- 4.9.2 Pharma Mar SA Business Overview
- 4.9.3 Pharma Mar SA Marine Pharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Pharma Mar SA Marine Pharmaceuticals Product Portfolio
- 4.9.5 Pharma Mar SA Recent Developments
- 4.10 Croda
- 4.10.1 Croda Company Information
- 4.10.2 Croda Business Overview
- 4.10.3 Croda Marine Pharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Croda Marine Pharmaceuticals Product Portfolio
- 4.10.5 Croda Recent Developments
- 4.11 GNC
- 4.11.1 GNC Company Information
- 4.11.2 GNC Business Overview
- 4.11.3 GNC Marine Pharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 GNC Marine Pharmaceuticals Product Portfolio
- 4.11.5 GNC Recent Developments
- 4.12 GSK
- 4.12.1 GSK Company Information
- 4.12.2 GSK Business Overview
- 4.12.3 GSK Marine Pharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 GSK Marine Pharmaceuticals Product Portfolio
- 4.12.5 GSK Recent Developments
- 4.13 TerSera Therapeutics
- 4.13.1 TerSera Therapeutics Company Information
- 4.13.2 TerSera Therapeutics Business Overview
- 4.13.3 TerSera Therapeutics Marine Pharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 TerSera Therapeutics Marine Pharmaceuticals Product Portfolio
- 4.13.5 TerSera Therapeutics Recent Developments
- 4.14 Nordic Naturals
- 4.14.1 Nordic Naturals Company Information
- 4.14.2 Nordic Naturals Business Overview
- 4.14.3 Nordic Naturals Marine Pharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Nordic Naturals Marine Pharmaceuticals Product Portfolio
- 4.14.5 Nordic Naturals Recent Developments
- 4.15 Carlson Labs
- 4.15.1 Carlson Labs Company Information
- 4.15.2 Carlson Labs Business Overview
- 4.15.3 Carlson Labs Marine Pharmaceuticals Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Carlson Labs Marine Pharmaceuticals Product Portfolio
- 4.15.5 Carlson Labs Recent Developments
5 Global Marine Pharmaceuticals Market Scenario by Region
- 5.1 Global Marine Pharmaceuticals Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Marine Pharmaceuticals Sales by Region: 2021-2032
- 5.2.1 Global Marine Pharmaceuticals Sales by Region: 2021-2026
- 5.2.2 Global Marine Pharmaceuticals Sales by Region: 2027-2032
- 5.3 Global Marine Pharmaceuticals Revenue by Region: 2021-2032
- 5.3.1 Global Marine Pharmaceuticals Revenue by Region: 2021-2026
- 5.3.2 Global Marine Pharmaceuticals Revenue by Region: 2027-2032
- 5.4 North America Marine Pharmaceuticals Market Facts & Figures by Country
- 5.4.1 North America Marine Pharmaceuticals Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Marine Pharmaceuticals Sales by Country (2021-2032)
- 5.4.3 North America Marine Pharmaceuticals Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Marine Pharmaceuticals Market Facts & Figures by Country
- 5.5.1 Europe Marine Pharmaceuticals Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Marine Pharmaceuticals Sales by Country (2021-2032)
- 5.5.3 Europe Marine Pharmaceuticals Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Marine Pharmaceuticals Market Facts & Figures by Country
- 5.6.1 Asia Pacific Marine Pharmaceuticals Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Marine Pharmaceuticals Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Marine Pharmaceuticals Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Marine Pharmaceuticals Market Facts & Figures by Country
- 5.7.1 South America Marine Pharmaceuticals Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Marine Pharmaceuticals Sales by Country (2021-2032)
- 5.7.3 South America Marine Pharmaceuticals Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Marine Pharmaceuticals Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Marine Pharmaceuticals Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Marine Pharmaceuticals Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Marine Pharmaceuticals Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Marine Pharmaceuticals Sales by Type (2021-2032)
- 6.1.1 Global Marine Pharmaceuticals Sales by Type (2021-2032) & (M units)
- 6.1.2 Global Marine Pharmaceuticals Sales Market Share by Type (2021-2032)
- 6.2 Global Marine Pharmaceuticals Revenue by Type (2021-2032)
- 6.2.1 Global Marine Pharmaceuticals Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Marine Pharmaceuticals Revenue Market Share by Type (2021-2032)
- 6.3 Global Marine Pharmaceuticals Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Marine Pharmaceuticals Sales by Application (2021-2032)
- 7.1.1 Global Marine Pharmaceuticals Sales by Application (2021-2032) & (M units)
- 7.1.2 Global Marine Pharmaceuticals Sales Market Share by Application (2021-2032)
- 7.2 Global Marine Pharmaceuticals Revenue by Application (2021-2032)
- 7.2.1 Global Marine Pharmaceuticals Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Marine Pharmaceuticals Revenue Market Share by Application (2021-2032)
- 7.3 Global Marine Pharmaceuticals Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Marine Pharmaceuticals Value Chain Analysis
- 8.1.1 Marine Pharmaceuticals Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Marine Pharmaceuticals Production Mode & Process
- 8.2 Marine Pharmaceuticals Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Marine Pharmaceuticals Distributors
- 8.2.3 Marine Pharmaceuticals Customers
9 Global Marine Pharmaceuticals Analyzing Market Dynamics
- 9.1 Marine Pharmaceuticals Industry Trends
- 9.2 Marine Pharmaceuticals Industry Drivers
- 9.3 Marine Pharmaceuticals Industry Opportunities and Challenges
- 9.4 Marine Pharmaceuticals Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst